4.3 Editorial Material

Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis

期刊

JORNAL DE PEDIATRIA
卷 91, 期 2, 页码 108-110

出版社

SOC BRASIL PEDIATRIA
DOI: 10.1016/j.jped.2014.11.001

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa

William C. McMahon, Gaurav Kwatra, Alane Izu, Anthonet L. Koen, Johann Greffrath, Lee Fairlie, Faeezah Patel, Christian K. Mukendi, Nkululeko J. Mbele, Rushil Lala, Wendy A. Burgers, Marta C. Nunes, Clare L. Cutland, Sarah C. Gilbert, Teresa Lambe, Andrew J. Pollard, Shabir A. Madhi

Summary: This study aimed to investigate the T-cell responses specific to SARS-CoV-2 in black Africans with and without HIV after receiving the AZD1222 vaccine. The study found that the T-cell responses were comparable between HIV-uninfected individuals and people living with HIV who were on stable antiretroviral therapy. In addition, individuals with prior SARS-CoV-2 infection showed a heightened T-cell response after receiving the AZD1222 vaccine.
Article Immunology

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Zourab Bebia, Osvaldo Reyes, Robert Jeanfreau, Anu Kantele, Ruth Graciela De Leon, Marta Garcia Sanchez, Peyman Banooni, Glenn J. Gardener, Jose Luis Bartha Rasero, Maria Begona Encinas Pardilla, Joanne M. Langley, Claudio Maanon Di Leo, Elisabeth Botelho-Nevers, Jim Buttery, Helene Laurichesse, Shabir A. Madhi, Adrian Martin Garcia, Thorsten Stanley, Tiphaine Barjat, Rebecca Griffith, Maria Mercedes Castrejon-Alba, Magali de Heusch, Ilse Dieussaert, Melanie Hercor, Patricia Lese, Hui Qian, Antonella N. Tullio, Ouzama Henry

Summary: Maternal vaccination with RSVPreF3 during late pregnancy has an acceptable safety risk profile and induces robust RSV-specific immune responses with successful antibody transfer to newborns.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

Yvette N. N. Lowensteyn, Joukje E. E. Willemsen, Natalie I. I. Mazur, Nienke M. M. Scheltema, Nynke C. J. van Haastregt, Amber A. A. ten Buuren, Ichelle van Roessel, Dunja Scheepmaker, Harish Nair, Peter M. M. van de Ven, Louis J. J. Bont

Summary: This study provides the first global case series of children dying with nosocomial RSV infection. Infant-targeted immunization strategies in the future could prevent the majority of nosocomial RSV-related deaths. Although nosocomial RSV deaths are expected to occur at highest rates in low- and lower-middle-income countries (LMICs), the reported number of these deaths was low in these countries. Hospital-based surveillance is needed to capture the full burden of nosocomial RSV mortality in LMICs.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Pediatrics

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Eric A. F. Simoes, Shabir A. Madhi, William J. Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabanas, Manuel Baca Cots, Joseph B. Domachowske, Maria L. Garcia-Garcia, Ineta Grantina, Kim A. Nguyen, Heather J. Zar, Anna Berglind, Celeste Cummings, M. Pamela Griffin, Therese Takas, Yuan Yuan, Ulrika Waehlby Hamrin, Amanda Leach, Tonya Villafana

Summary: This study evaluated the efficacy of nirsevimab using a weight-banded dosing regimen in infants born between 29 weeks gestational age and full term. The results showed that a single dose of nirsevimab protected healthy infants born at term or preterm from RSV lower respiratory tract infection, reducing the incidence of hospital admissions and severe cases associated with RSV. Therefore, nirsevimab has the potential to alleviate the burden of infant RSV disease.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Article Public, Environmental & Occupational Health

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

Emily R. Smith, Erin Oakley, Gargi Wable Grandner, Kacey Ferguson, Fouzia Farooq, Yalda Afshar, Mia Ahlberg, Homa Ahmadzia, Victor Akelo, Grace Aldrovandi, Beth A. Tippett Barr, Elisa Bevilacqua, Justin S. Brandt, Nathalie Broutet, Irene Fernandez Buhigas, Jorge Carrillo, Rebecca Clifton, Jeanne Conry, Erich Cosmi, Fatima Crispi, Francesca Crovetto, Camille Delgado-Lopez, Hema Divakar, Amanda J. Driscoll, Guillaume Favre, Valerie J. Flaherman, Chris Gale, Maria M. Gil, Sami L. Gottlieb, Eduard Gratacos, Olivia Hernandez, Stephanie Jones, Erkan Kalafat, Sammy Khagayi, Marian Knight, Karen Kotloff, Antonio Lanzone, Kirsty Le Doare, Christoph Lees, Ethan Litman, Erica M. Lokken, Valentina Laurita Longo, Shabir A. Madhi, Laura A. Magee, Raigam Jafet Martinez-Portilla, Elizabeth M. McClure, Tori D. Metz, Emily S. Miller, Deborah Money, Sakita Moungmaithong, Edward Mullins, Jean B. Nachega, Marta C. Nunes, Dickens Onyango, Alice Panchaud, Liona C. Poon, Daniel Raiten, Lesley Regan, Gordon Rukundo, Daljit Sahota, Allie Sakowicz, Jose Sanin-Blair, Jonas Soderling, Olof Stephansson, Marleen Temmerman, Anna Thorson, Jorge E. Tolosa, Julia Townson, Miguel Valencia-Prado, Silvia Visentin, Peter von Dadelszen, Kristina Adams Waldorf, Clare Whitehead, Murat Yassa, Jim M. Tielsch

Summary: Despite heterogeneity in study design and quality, a sequential, prospective meta-analysis found that SARS-CoV-2 infection during pregnancy increases the risk of maternal mortality, severe maternal morbidity, and neonatal morbidity. However, there is no association with stillbirth or intrauterine growth restriction. The findings highlight the importance of preventing and managing SARS-CoV-2 infection in pregnant women. Overall, the study is rated 8 out of 10 in terms of importance.

BMJ GLOBAL HEALTH (2023)

Article Infectious Diseases

In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) dataset

Shubhada Hooli, Carina King, Eric D. McCollum, Tim Colbourn, Norman Lufesi, Charles Mwansambo, Christopher J. Gregory, Somsak Thamthitiwat, Clare Cutland, Shabir Ahmed Madhi, Marta C. Nunes, Bradford D. Gessner, Tabish Hazir, Joseph L. Mathew, Emmanuel Addo-Yobo, Noel Chisaka, Mumtaz Hassan, Patricia L. Hibberd, Prakash Jeena, Juan M. Lozano, William B. MacLeod, Archana Patel, Donald M. Thea, Ngoc Tuong Vy Nguyen, Syed MA. Zaman, Raul O. Ruvinsky, Marilla Lucero, Cissy B. Kartasasmita, Claudia Turner, Rai Asghar, Salem Banajeh, Imran Iqbal, Irene Maulen-Radovan, Greta Mino-Leon, Samir K. Saha, Mathuram Santosham, Sunit Singhi, Shally Awasthi, Ashish Bavdekar, Monidarin Chou, Pagbajabyn Nymadawa, Jean-William Pape, Glaucia Paranhos-Baccala, Valentina Sanchez Picot, Mala Rakoto-Andrianarivelo, Vanessa Rouzier, Graciela Russomando, Mariam Sylla, Philippe Vanhems, Jianwei Wang, Sudha Basnet, Tor A. Strand, Mark I. Neuman, Luis Martinez Arroyo, Marcela Echavarria, Shinjini Bhatnagar, Nitya Wadhwa, Rakesh Lodha, Satinder Aneja, Angela Gentile, Mandeep Chadha, Siddhivinayak Hirv, Kerry-Ann F. O'Grady, Alexey W. Clara, Chris A. Rees, Harry Campbell, Harish Nair, Jennifer Falconer, Linda J. Williams, Margaret Horne, Shamim A. Qazi, Yasir Bin Nisar

Summary: This study found that pulse oximetry monitoring can reduce the mortality risk of pediatric pneumonia and identified risk factors for in-hospital mortality of chest-indrawing pneumonia. The conclusion is that pulse oximetry should be integrated into hospital care for pediatric pneumonia in children under 5 years.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Infectious Diseases

Safety of COVID-19 booster dose: is the juice worth the squeeze?

Shabir A. Madhi, Alane Izu

LANCET INFECTIOUS DISEASES (2023)

Article Medicine, General & Internal

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

B. Kampmann, S. A. Madhi, I. Munjal, E. A. F. Simoes, B. A. Pahud, C. Llapur, J. Baker, G. Perez Marc, D. Radley, E. Shittu, J. Glanternik, H. Snaggs, J. Baber, P. Zachariah, S. L. Barnabas, M. Fausett, T. Adam, N. Perreras, M. A. Van Houten, A. Kantele, L. -M Huang, L. J. Bont, T. Otsuki, S. L. Vargas, J. Gullam, B. Tapiero, R. T. Stein, F. P. Polack, H. J. Zar, N. B. Staerke, M. Duron Padilla, P. C. Richmond, K. Koury, K. Schneider, E. V. Kalinina, D. Cooper, K. U. Jansen, A. S. Anderson, K. A. Swanson, W. C. Gruber, A. Gurtman

Summary: Vaccination of pregnant women with RSVpreF vaccine was effective in reducing severe RSV-associated lower respiratory tract illness in infants. The vaccine showed 81.8% efficacy within 90 days and 69.4% efficacy within 180 days. The vaccine was found to be safe for both mothers and infants.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Letter Medicine, General & Internal

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

William J. Muller, Shabir A. Madhi, Beatriz Seoane Nunez, Manuel Baca Cots, Miroslava Bosheva, Ron Dagan, Laura L. Hammitt, Conrado J. Llapur, Jose M. Novoa, Xavier Saez Llorens, Amy Grenham, Elizabeth J. Kelly, Vaishali S. Mankad, Manish Shroff, Therese Takas, Amanda Leach, Tonya Villafana

Summary: Nirsevimab, a monoclonal antibody, effectively prevents hospitalization and severe lower respiratory tract infection in term and late-preterm infants caused by respiratory syncytial virus (RSV).

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Virology

Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study

Shabir A. A. Madhi, Gaurav Kwatra, Jonathan E. E. Myers, Waasila Jassat, Nisha Dhar, Christian K. K. Mukendi, Lucille Blumberg, Richard Welch, Alane Izu, Portia C. C. Mutevedzi

Summary: We conducted an epidemiological survey in South Africa to determine the seroprevalence of SARS-CoV-2 antibodies and analyzed epidemiologic trends in Gauteng Province. Despite low COVID-19 vaccination coverage, the overall seropositivity for SARS-CoV-2 was high, indicating a high infection rate during the BA.1-dominant wave. The risk of SARS-CoV-2 infection fatality was significantly lower during the BA.1-dominant wave compared to the pre-BA.1 waves for recorded deaths and estimated excess mortality.

VIRUSES-BASEL (2023)

Review Immunology

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, Paul Moss, Jeremy P. Kamil, Sandra Ciesek, Alexander Muik, Oezlem Tuereci

Summary: The Omicron variant of SARS-CoV-2, first detected in late 2021, has caused waves of infections with different sub-lineages becoming dominant over time. It generally causes milder disease compared to earlier variants, but has overwhelmed healthcare systems in countries with low population immunity. Pediatric admissions during Omicron waves have been higher than previous waves. Omicron sub-lineages partially escape vaccine-elicited antibodies, highlighting the need for variant-adapted vaccines to improve protection.

FRONTIERS IN IMMUNOLOGY (2023)

Article Medicine, General & Internal

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus

S. A. Madhi, A. S. Anderson, J. Absalon, D. Radley, R. Simon, B. Jongihlati, R. Strehlau, A. M. van Niekerk, A. Izu, N. Naidoo, G. Kwatra, Y. Ramsamy, M. Said, S. Jones, L. Jose, L. Fairlie, S. L. Barnabas, R. Newton, S. Munson, Z. Jefferies, D. Pavliakova, N. C. Silmon de Monerri, E. Gomme, J. L. Perez, D. A. Scott, W. C. Gruber, K. U. Jansen

Summary: This study evaluated the safety and immunogenicity of a hexavalent vaccine in pregnant women and found that it reduced the risk of group B streptococcal disease in newborns. The study also identified specific antibody concentrations associated with a reduced risk of disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Multidisciplinary Sciences

Metagenomic sequencing of post-mortem tissue samples for the identification of pathogens associated with neonatal deaths

Vicky L. Baillie, Shabir A. Madhi, Vida Ahyong, Courtney P. Olwagen

Summary: In this study, metagenomic sequencing was used to identify pathogens associated with neonatal deaths and its results were compared with conventional methods. The study showed that metagenomic sequencing successfully detected pathogens in post-mortem samples and even identified additional pathogens in cases where causative pathogens were not found. This approach could improve patient outcomes and assist in antibiotic stewardship.

NATURE COMMUNICATIONS (2023)

Review Medicine, General & Internal

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data

Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian P. T. Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A. Madhi, Kim Mulholland, Andrew J. Pollard, Beth Temple, Merryn Voysey

Summary: This systematic review and meta-analysis found differences in immunogenicity and efficacy between pneumococcal conjugate vaccines (PCV13 and PCV10). PCV13 demonstrated higher immunogenicity for specific serotypes and lower risk of seroinfection compared to PCV10. Additionally, a higher antibody response after vaccination was associated with a decreased risk of subsequent infection.

ECLINICALMEDICINE (2023)

Article Public, Environmental & Occupational Health

Neural tube defects as a cause of death among stillbirths , infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network

Lola Madrid, Kartavya J. Vyas, Vijaya Kancherla, Haleluya Leulseged, Parminder S. Suchdev, Quique Bassat, Samba Sow, Shams El Arifeen, ShabirA Madhi, Dickens Onyango, Ikechukwu Ogbuanu, J. Anthony G. Scott, Dianna Blau, Inacio Mandomando, Adama M. Keita, Emily S. Gurley, Sana Mahtab, Victor Akelo, Sulaiman Sannoh, Yenenesh Tilahun, Rosauro Varo, Uma Onwuchekwa, Afruna Rahman, Yasmin Adam, Richard Omore, Sandra Lako, Elisio Xerinda, Kazi Munisul Islam, Amy Wise, Beth A. Tippet-Barr, Erick Kaluma, Sara Ajanovic, Karen L. Kotloff, Mohammad Zahid Hossain, Portia Mutevedzi, Milagritos Tapia, Emily Rogena, Francis Moses, Cynthia G. Whitney, Nega Assefa

Summary: This study aimed to estimate the mortality attributed to neural tube defects in seven countries in sub-Saharan Africa and southeast Asia. The results showed that neural tube defects were a common cause of stillbirth and neonatal deaths, especially in Ethiopia. Therefore, implementing necessary interventions such as mandatory folic acid fortification could reduce mortality due to neural tube defects.

LANCET GLOBAL HEALTH (2023)

暂无数据